<unk>  is a endocrine agent that is FDA approved for the treatment of the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy.. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include .
Metreleptin
Thiotepa
Ceruletide
Bryostatin
Somatrem
Tetracosactide
Pentostatin
Botulinum toxin